Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Does Creatine Improve Corticosteroid-Mediated Facial Nerve Healing in a Rat Model?
Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine.
Carboplatin induces optic nerve oligodendrocyte loss and impairs myelin sheath microstructure in a mouse model of neurofibromatosis type 1 (NF1).
The value of double inversion recovery MRI sequences in the diagnosis of inflammatory demyelinating diseases of the spinal cord.
French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.
A multi-outcome prognostic score for therapeutic responses in multiple sclerosis.
Human blood-brain barrier spheroid models for the evaluation of drugs targeting brain vascular inflammation.
A mathematical model for inflammation and demyelination in multiple sclerosis.
Local glucocorticoid synthesis and receptor signaling in cerebellar demyelination during canine distemper virus infection.
Localized PD-1 CAR T therapy reprograms neuroinflammation.
Itolizumab targets the CD6-ALCAM axis to limit T-cell responses and brain barrier diapedesis in multiple sclerosis.
Chronic pain despite lower lesion burden in double-seronegative longitudinally extensive transverse myelitis.
Executive Summary of the Malaysian consensus statements for the diagnosis and management of neuromyelitis optica spectrum disorder (NMOSD).
Pages
« first
‹ previous
…
1039
1040
1041
1042
1043
1044
1045
1046
1047